What's breaking now, across thousands of outlets.
Goldman Sachs Chief Regional Equity Strategist for Asia Pacific Timothy Moe explains why AI-related stocks remain good investments despite rising rates on government debt. He speaks as a global bond selloff extends into Asia while elevated oil prices stoke inflation concerns. (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.
[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Friday (Sep 25):
The ringgit is expected to trade between RM4.08 and RM4.10 against the US dollar today, says an analyst.
Revolut is moving ahead with the completion of its acquisition of Argentine bank Banco Cetelem Argentina S.A. after receiving approval from the Central Bank of Argentina, the company said in a…
The stock is roughly 1 per cent gain away from joining an elite group of companies worth at least S$2.5 trillion.
Oil climbs about 3% after Houthi missile attack on Saudi Arabia revives supply disruption fears.
